rTMS Research

Our TMS research center houses the super- rapid2 TMS brain stimulator (The Magstim Company, Wales, UK) that can be used for single- pulse, repetitive, and session mode TMS protocols; it consists of a biphasic stimulator that combines stimulation frequencies from 1 Hz to 100 Hz, a 70 mm figure-of-eight cooled TMS coil, and an integrated two-channel EMG.

The focus of our researches are to explore the multimodality combination of rTMS and other neuroimaging techniques, such as fMRI and PET, to monitor function changes generated by applying high-frequency rTMS trains in the cortical area. We aim to use such tools to address mayor scientific questions about how drug addiction, obesity, depression, and other disorders affect the brain.

We also aim to promote translational research, using the extensive knowledge obtained about changes in neuronal activity that result from drug effects and the progression of neurological diseases, to promote and support the development of new tools for treating these illnesses.

Top of Page

Last Modified: February 1, 2008
Please forward all questions about this site to: Elisabeth Caparelli